Loading...
When karyotype is decisive for myelodysplastic syndromes diagnosis
INTRODUCTION: The myelodysplastic syndromes (MDS) are a group of heterogeneous clonal hematopoietic stem cell disorders that results in peripheral blood (PB) cytopenias and bone marrow (BM) dysplasia. Dysplasia is the hallmark of the disorder, and must exceed the threshold of 10%. Conventional karyo...
Na minha lista:
| Udgivet i: | Hematol Transfus Cell Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Sociedade Brasileira de Hematologia e Hemoterapia
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6978531/ https://ncbi.nlm.nih.gov/pubmed/31395457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.htct.2019.03.004 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|